APA (7th ed.) Citation

Vijayan, M. (2017). Characteristics of epidermal growth factor receptor (EGFR)-Mutated Non Small Cell Lung Carcinoma (NSCLC)-patients who developed resistance to first or second generation Egfrtyrosine Kinase Inhibitor (TKI) Therapy through T790M mutation / Vijayan Munusamy.

Chicago Style (17th ed.) Citation

Vijayan, Munusamy. Characteristics of Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Carcinoma (NSCLC)-patients Who Developed Resistance to First or Second Generation Egfrtyrosine Kinase Inhibitor (TKI) Therapy Through T790M Mutation / Vijayan Munusamy. 2017.

MLA (9th ed.) Citation

Vijayan, Munusamy. Characteristics of Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Carcinoma (NSCLC)-patients Who Developed Resistance to First or Second Generation Egfrtyrosine Kinase Inhibitor (TKI) Therapy Through T790M Mutation / Vijayan Munusamy. 2017.